ALA-101

· Arovella Therapeutics Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALA-101, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. [Phase 1]